Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator "FASTFlo tPA"


Phase 1 Results N/A

Summary of Purpose

To assess the safety and feasibility of using the NeuroFlo catheter to treat acute ischemic stroke patients following administration of intravenous tPA.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 March 2010.

1 May 2007 2 Nov 2009 1 Jul 2009 1 Jan 2010 1 Mar 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Single Group Assignment


Not available